SCHEMBL4853574

SCHEMBL4853574

Cc1ccccc1-c1ccc(OCCN(C)C)c(C(=O)/C=C/c2ccccc2CN(C)C(C)(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 5/20 0.43
HRH1 P35367 2/20 0.39
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MCHR1 Q99705 2/20 0.36
BCHE P06276 2/20 0.36
ACHE P22303 2/20 0.36
ESR1 P03372 1/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PTPN11 Q06124 1/20 0.34
AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854860 1.00 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4847208 0.93 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4852352 0.93 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4853568 0.92 SLC6A9 (0.46) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4847435 0.92 SLC6A9 (0.46) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4853580 0.91 SLC6A9 (0.40) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4852918 0.90 SLC6A9 (0.40) SLC6A9KDM4EALDH1A1SMN1; SMN2MCHR1
SCHEMBL4853354 0.90 SLC6A9 (0.40) SLC6A9KDM4EALDH1A1SMN1; SMN2MCHR1
SCHEMBL4854689 0.90 SLC6A9 (0.46) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4855044 0.90 SLC6A9 (0.46) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed